发明名称 |
CRYSTALLINE FORM OF A QUINOLINONE-CARBOXAMIDE COMPOUND |
摘要 |
The invention provides a crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with 5-HT4 receptor activity, and processes useful for preparing such crystalline salt forms. |
申请公布号 |
EP1874766(A2) |
申请公布日期 |
2008.01.09 |
申请号 |
EP20060740692 |
申请日期 |
2006.04.05 |
申请人 |
THERAVANCE, INC. |
发明人 |
FATHEREE, PAUL R.;TURNER, S. DEREK;GOLDBLUM, ADAM;CHAO, ROBERT;GENOV, DANIEL |
分类号 |
C07D451/04;A61K31/40;A61P1/00 |
主分类号 |
C07D451/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|